clarithromycin has been researched along with pyrimethamine in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (55.56) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 5 (27.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Boothroyd, JC; Choi, JY; Fu, H; Harvey, C; Khosla, C; Lee, Y; Ravindran, S; Roush, WR | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Araujo, FG; Lin, T; Prokocimer, P; Remington, JS | 1 |
| Chauvin, JP; Fernandez-Martin, J; Leport, C; Meyohas, MC; Morlat, P; Vilde, JL | 1 |
| Chastang, C; Derouin, F | 1 |
| Hughes, WT; Killmar, JT; Oz, HS | 1 |
| Alder, J; Clement, JC; Hutch, T; Meulbroek, JA | 1 |
| Cardenal, C; Gatell, JM; Guelar, A; Mallolas, J; Miró, JM; Soriano, E; Zamora, L | 1 |
| Derouin, F; Pudney, M; Romand, S | 1 |
| Chene, G; Dupon, M; Lacoste, D; Morlat, P; Pellegrin, JL; Ragnaud, JM | 1 |
| Alba, D; del Arco, A; Molina, F; Ripoll, MM | 1 |
| Barchiesi, F; Cirioni, O; Giacometti, A; Scalise, G | 1 |
| Asencio Marchante, R; Lissen Otero, E | 1 |
| Cheng, B | 1 |
1 review(s) available for clarithromycin and pyrimethamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
17 other study(ies) available for clarithromycin and pyrimethamine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Chemistry and biology of macrolide antiparasitic agents.
Topics: Anti-Bacterial Agents; Antiparasitic Agents; Cells, Cultured; Humans; Macrolides; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Models, Molecular; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Toxoplasma | 2011 |
Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Animals; Brain Diseases; Chronic Disease; Clarithromycin; Cysts; Drug Therapy, Combination; Female; Humans; Mice; Mice, Inbred CBA; Pyrimethamine; Sulfadiazine; Toxoplasma; Toxoplasmosis, Animal | 1992 |
Pyrimethamine-clarithromycin combination for therapy of acute Toxoplasma encephalitis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Brain; Clarithromycin; Drug Therapy, Combination; Erythromycin; Pyrimethamine; Tomography, X-Ray Computed; Toxoplasmosis, Cerebral | 1991 |
Activity in vitro against Toxoplasma gondii of azithromycin and clarithromycin alone and with pyrimethamine.
Topics: Animals; Azithromycin; Clarithromycin; Drug Interactions; Erythromycin; Pyrimethamine; Regression Analysis; Toxoplasma | 1990 |
Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model.
Topics: Animals; Anti-Infective Agents; Atovaquone; Azithromycin; Clarithromycin; Clindamycin; Clinical Trials as Topic; Dapsone; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Humans; Naphthoquinones; Pentamidine; Pneumocystis Infections; Proguanil; Pyrimethamine; Rats; Sulfadoxine; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1994 |
Treatment of experimental Toxoplasma gondii infection by clarithromycin-based combination therapy with minocycline or pyrimethamine.
Topics: AIDS-Related Opportunistic Infections; Animals; Clarithromycin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Mice; Minocycline; Pyrimethamine; Sulfamethoxazole; Toxoplasma; Toxoplasmosis, Animal | 1994 |
[Therapeutic alternatives for cases of cerebral toxoplasmosis in patients with AIDS: clarithromycin and atovaquone].
Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Atovaquone; Clarithromycin; Clindamycin; Drug Therapy, Combination; Folic Acid; Humans; Male; Naphthoquinones; Pyrimethamine; Sulfadiazine; Toxoplasma; Toxoplasmosis, Cerebral | 1994 |
In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii.
Topics: Animals; Antiprotozoal Agents; Atovaquone; Clarithromycin; Coccidiostats; Drug Combinations; Drug Interactions; Enzyme-Linked Immunosorbent Assay; Kinetics; Mice; Minocycline; Naphthoquinones; Pyrimethamine; Sulfadiazine; Toxoplasma; Toxoplasmosis, Animal | 1993 |
[Cerebral toxoplasmosis in AIDS. 73 cases. Clinical Epidemiology Group on AIDS in Aquitania].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Clarithromycin; Clindamycin; Drug Therapy, Combination; Female; France; Humans; Leucovorin; Male; Middle Aged; Pyrimethamine; Recurrence; Retrospective Studies; Sulfadiazine; Tomography, X-Ray Computed; Toxoplasmosis, Cerebral | 1993 |
[Clarithromycin in the treatment of cerebral toxoplasmosis associated with HIV infection].
Topics: Adult; Clarithromycin; Drug Therapy, Combination; Female; HIV Infections; Humans; Pyrimethamine; Toxoplasmosis, Cerebral | 1993 |
Inhibition of growth of Pneumocystis carinii by lactoferrins alone and in combination with pyrimethamine, clarithromycin and minocycline.
Topics: Animals; Antimalarials; Cattle; Cell Line; Clarithromycin; Drug Therapy, Combination; Epithelial Cells; Humans; Lactoferrin; Minocycline; Parasitic Sensitivity Tests; Pneumocystis; Pyrimethamine | 2000 |
[Secondary prevention of opportunistic infections in HIV-infected patients].
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antiprotozoal Agents; Antitubercular Agents; Antiviral Agents; Clarithromycin; Cytomegalovirus Infections; Drug Therapy, Combination; Ethambutol; Ganciclovir; Humans; Leucovorin; Mycobacterium avium-intracellulare Infection; Pneumonia, Pneumocystis; Pyrimethamine; Recurrence; Rifabutin; Sulfadiazine; Sulfamethoxazole; Toxoplasmosis; Trimethoprim | 2001 |
Preventing opportunistic infections.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Clarithromycin; Clindamycin; Clinical Trials as Topic; Clotrimazole; Cytomegalovirus Infections; Dapsone; Fluconazole; Ganciclovir; Humans; Itraconazole; Leucovorin; Mycobacterium avium-intracellulare Infection; Mycoses; Pentamidine; Pneumonia, Pneumocystis; Pyrimethamine; Rifabutin; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; Valacyclovir; Valine | 1995 |